Hyppää sisältöön
    • Suomeksi
    • In English
  • Suomeksi
  • In English
  • Kirjaudu
Näytä aineisto 
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
  •   Etusivu
  • 3. UTUCris-artikkelit
  • Rinnakkaistallenteet
  • Näytä aineisto
JavaScript is disabled for your browser. Some features of this site may not work without it.

Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe

Teepen J.; Kaatsch P.; Jankovic M.; Wiebe T.; Wesenberg F.; Jakab Z.; Kremer L.; Øfstaas H.; Terenziani M.; Kuonen R.; Byrne J.; Winther J.; Bárdi E.; Garwicz S.; Bagnasco F.; Grabow D.; Gudmundsdottir T.; Haupt R.; Winter D.; Haddy N.; Vu-Bezin G.; Hjorth L.; Zaletel L.; Guha J.; Feijen E.; Skinner R.; Merletti F.; Linge H.; Lähteenmäki P.; Kaiser M.; Fidler M.; Bright C.; Bautz A.; Reulen R.; Allodji R.; Kuehni C.; de Vathaire F.; Ronckers C.; Maule M.; Hawkins M.

Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe

Teepen J.
Kaatsch P.
Jankovic M.
Wiebe T.
Wesenberg F.
Jakab Z.
Kremer L.
Øfstaas H.
Terenziani M.
Kuonen R.
Byrne J.
Winther J.
Bárdi E.
Garwicz S.
Bagnasco F.
Grabow D.
Gudmundsdottir T.
Haupt R.
Winter D.
Haddy N.
Vu-Bezin G.
Hjorth L.
Zaletel L.
Guha J.
Feijen E.
Skinner R.
Merletti F.
Linge H.
Lähteenmäki P.
Kaiser M.
Fidler M.
Bright C.
Bautz A.
Reulen R.
Allodji R.
Kuehni C.
de Vathaire F.
Ronckers C.
Maule M.
Hawkins M.
Katso/Avaa
Publisher's version (795.1Kb)
Lataukset: 

doi:10.1093/jnci/djx165
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2021042718871
Tiivistelmä

Introduction: We investigate the risks of subsequent primary bone cancers after childhood and adolescent cancer in 12
European countries. For the first time, we satisfactorily address the risks beyond 40 years from diagnosis and beyond 40 years
of age among all survivors.
Methods: This largest-ever assembled cohort comprises 69 460 five-year survivors of cancer diagnosed before age 20 years.
Standardized incidence ratios, absolute excess risks, and multivariable-adjusted relative risks and relative excess risks were
calculated. All statistical tests were two-sided.
Results: Overall, survivors were 21.65 times (95% confidence interval ¼ 18.97 to 24.60 times) more likely to be diagnosed with a
subsequent primary bone cancer than expected from the general population. The greatest excess numbers of bone cancers were
observed after retinoblastoma, bone sarcoma, and soft tissue sarcoma. The excess number of bone cancers declined linearly with both
years since diagnosis and attained age (all P < .05). Beyond 40years from diagnosis and age 40 years, there were at most 0.45 excess
bone cancers among all survivors per 10000 person-years at risk; beyond 30years from diagnosis and age 30 years, there were at most
5.02 excess bone cancers after each of retinoblastoma, bone sarcoma, and soft tissue sarcoma, per 10000 person-years at risk.
Conclusions: For all survivors combined and the cancer groups with the greatest excess number of bone cancers, the excess
numbers observed declined with both age and years from diagnosis. These results provide novel, reliable, and unbiased
information about risks and risk factors among long-term survivors of childhood and adolescent cancer.

Kokoelmat
  • Rinnakkaistallenteet [19207]

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste
 

 

Tämä kokoelma

JulkaisuajatTekijätNimekkeetAsiasanatTiedekuntaLaitosOppiaineYhteisöt ja kokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy

Turun yliopiston kirjasto | Turun yliopisto
julkaisut@utu.fi | Tietosuoja | Saavutettavuusseloste